BlackRock Health Sciences Trust (BME)
About BlackRock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $516.2M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $516.2M
- Dividend yield
- 7.34%
- Shares outstanding
- 12.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 29, 2005
BlackRock Health Sciences Trust (BME) Stock Price
- Trading near its 52-week high.
- Pays a dividend yielding about 7.34% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BlackRock Health Sciences Trust.
Write a review
News about BlackRock Health Sciences Trust
News & sentiment via Polygon.io
BlackRock Health Sciences Trust: frequently asked questions
Is BlackRock Health Sciences Trust an American company?
BlackRock Health Sciences Trust is a US-based company headquartered in Wilmington, Delaware, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BlackRock Health Sciences Trust headquartered?
BlackRock Health Sciences Trust is headquartered in Wilmington, Delaware, United States.
Is BlackRock Health Sciences Trust publicly traded?
Yes — BlackRock Health Sciences Trust is a publicly traded company. Its stock trades under the ticker symbol BME on the NYSE.
